Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris Clinical research trials and To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris. To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris clinical trial. Participants frequently obtain the most expert healthcare available for their To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "T" Clinical Trials Conditions > To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris

To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris



To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris

For Condition: Psoriasis
Status: Recruiting
Sponsor(s): Protein Design Labs ,
Synopsis: This study is designed to study disease relapse after NBUVB and how the administration of Daclizumab/placebo alters disease relapse.
Details: The first part of the study involves NB-UVB light treatment, a well-established treatment to treat psoriasis. In the second part, we are testing a drug known as Humanized CD25 Monoclonal Antibody (anti-TAC) or placebo to prevent disease relapse. Anti-TAC is an injectable medicine that is also designed to treat psoriasis by blocking a part of the immune system that we believe contributes to the disease.
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - extensive active psoriasis vulgaris, body surface area more than 10% if accompanied by psoriatic arthritis, - negative hepatitis and HIV, - no treatment with systemic drugs for 1 month prior to the start of a study - no treatment with topical medications for 2 weeks prior to the start of a study,
Total Enrollment: 30

Location and Contact Information:

Rockefeller University *Recruiting*
New York City,  New York,  10021
United States
Recruiting Pat  Gilleaudeau 212-327-8333


Additional Information:
Study ID Numbers:
  JKR-0337; 
Study Start Date: October 1997
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00050661

Other Psoriasis Studies:
1. Treatment of Psoriasis Using Acitretin in HIV-Positive Patients

2. To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris

3. Study of Topical Calcitriol in Children With Psoriasis

4. The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

5. Etanercept (Enbrel®) in Psoriasis - Pediatrics

Related Studies:

Other Psoriasis Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials

To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris

Modify your Search

  Other Psoriasis Clinical Trials
  Other New York Clinical Trials
  Other New York City Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103